Geravipoolvorn Voravit MD Roseville, MI - 48066

Geravipoolvorn Voravit MD is categorized under Internal Medicine Practitioners in Roseville, MI and active since 1975.

Geravipoolvorn Voravit MD was established in 1975, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Internal Medicine Practitioners business, which does work in the B2C market, and is classified as a Internal Medicine Practitioners, under code number 6211110 by the NAICS.

If you are seeking more information, feel free to contact Voravit Geravipoolvorn at the company’s single location by writing to 28345 Utica Road, Roseville, Michigan MI 48066 or by phoning (586) 772-8158. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Geravipoolvorn Voravit MD
Contact Person: Voravit Geravipoolvorn
Address: 28345 Utica Road, Roseville, Michigan 48066
Phone Number: (586) 772-8158
Annual Revenue (USD): $500.000 to $999.999
Founded: 1975
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2C (Business to Consumer)
Business Category: Internal Medicine Practitioners
SIC Code: 8011
NAICS Code: 6211110
Share This Business:

Geravipoolvorn Voravit MD was started in 1975 to provide professional Internal Medicine Practitioners under the SIC code 8011 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.

Feel free to contact Voravit Geravipoolvorn for inquiries that concern Geravipoolvorn Voravit MD by calling the company number (586) 772-8158, as your correspondence is most welcome. Additionally, the physical location of the single location of Geravipoolvorn Voravit MD can be found at the coordinates 42.50465,-82.93333 as well as the street address 28345 Utica Road in Roseville, Michigan 48066.

For its online presence, you may visit Geravipoolvorn Voravit MD’s website at and engage with its social media outlets through on Twitter and on Facebook.